LaBri's Body Health XPLODE 30 capsules Exclusively distribute… — Class I drug recall D-0122-2018
Terminated recall by EZWeightLossTX LLC, reported 2017-12-27, distributed nationwide. Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be
| Recall number | D-0122-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | EZWeightLossTX LLC, Corpus Christi, TX, United States |
| Recall initiated | 2017-07-24 |
| Classified | 2017-12-20 |
| Reported by FDA | 2017-12-27 |
| Terminated | 2021-02-10 |
| Distributed | Nationwide (US) |
| Quantity | 1,424 bottles |
| Reason classes | unapproved product |
Product
LaBri's Body Health XPLODE 30 capsules Exclusively distribute worldwide by LaBri's Body Health.
Reason for recall
Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplements: products found to be tainted with sibutramine making these unapproved drugs.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0122-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.